Global Drug of Abuse (DOA) Testing Consumables Market Insights and Forecast to 2028

Report ID: 1156399 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Drug of Abuse (DOA) Testing Consumables Product Introduction
    1.2 Market by Type
        1.2.1 Global Drug of Abuse (DOA) Testing Consumables Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Rapid Test Kits
        1.2.3 Assay Kits and Reagents
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Drug of Abuse (DOA) Testing Consumables Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Laboratories
        1.3.4 Workplace
        1.3.5 At-Home
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Estimates and Forecasts 2017-2028
    2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Estimates and Forecasts 2017-2028
    2.3 Global Drug of Abuse (DOA) Testing Consumables Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Drug of Abuse (DOA) Testing Consumables Sales by Region
        2.4.1 Global Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2022)
        2.4.2 Global Sales Drug of Abuse (DOA) Testing Consumables by Region (2023-2028)
    2.5 Global Drug of Abuse (DOA) Testing Consumables Revenue by Region
        2.5.1 Global Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2022)
        2.5.2 Global Drug of Abuse (DOA) Testing Consumables Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Drug of Abuse (DOA) Testing Consumables Sales by Manufacturers
        3.1.1 Global Top Drug of Abuse (DOA) Testing Consumables Manufacturers by Sales (2017-2022)
        3.1.2 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug of Abuse (DOA) Testing Consumables in 2021
    3.2 Global Drug of Abuse (DOA) Testing Consumables Revenue by Manufacturers
        3.2.1 Global Drug of Abuse (DOA) Testing Consumables Revenue by Manufacturers (2017-2022)
        3.2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Consumables Revenue in 2021
    3.3 Global Drug of Abuse (DOA) Testing Consumables Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Drug of Abuse (DOA) Testing Consumables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Drug of Abuse (DOA) Testing Consumables Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Drug of Abuse (DOA) Testing Consumables Sales by Type
        4.1.1 Global Drug of Abuse (DOA) Testing Consumables Historical Sales by Type (2017-2022)
        4.1.2 Global Drug of Abuse (DOA) Testing Consumables Forecasted Sales by Type (2023-2028)
        4.1.3 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2028)
    4.2 Global Drug of Abuse (DOA) Testing Consumables Revenue by Type
        4.2.1 Global Drug of Abuse (DOA) Testing Consumables Historical Revenue by Type (2017-2022)
        4.2.2 Global Drug of Abuse (DOA) Testing Consumables Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2028)
    4.3 Global Drug of Abuse (DOA) Testing Consumables Price by Type
        4.3.1 Global Drug of Abuse (DOA) Testing Consumables Price by Type (2017-2022)
        4.3.2 Global Drug of Abuse (DOA) Testing Consumables Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Drug of Abuse (DOA) Testing Consumables Sales by Application
        5.1.1 Global Drug of Abuse (DOA) Testing Consumables Historical Sales by Application (2017-2022)
        5.1.2 Global Drug of Abuse (DOA) Testing Consumables Forecasted Sales by Application (2023-2028)
        5.1.3 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2028)
    5.2 Global Drug of Abuse (DOA) Testing Consumables Revenue by Application
        5.2.1 Global Drug of Abuse (DOA) Testing Consumables Historical Revenue by Application (2017-2022)
        5.2.2 Global Drug of Abuse (DOA) Testing Consumables Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2028)
    5.3 Global Drug of Abuse (DOA) Testing Consumables Price by Application
        5.3.1 Global Drug of Abuse (DOA) Testing Consumables Price by Application (2017-2022)
        5.3.2 Global Drug of Abuse (DOA) Testing Consumables Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Drug of Abuse (DOA) Testing Consumables Market Size by Type
        6.1.1 North America Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2028)
        6.1.2 North America Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2028)
    6.2 North America Drug of Abuse (DOA) Testing Consumables Market Size by Application
        6.2.1 North America Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2028)
        6.2.2 North America Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2028)
    6.3 North America Drug of Abuse (DOA) Testing Consumables Market Size by Country
        6.3.1 North America Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2028)
        6.3.2 North America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Drug of Abuse (DOA) Testing Consumables Market Size by Type
        7.1.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2028)
        7.1.2 Europe Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2028)
    7.2 Europe Drug of Abuse (DOA) Testing Consumables Market Size by Application
        7.2.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2028)
        7.2.2 Europe Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2028)
    7.3 Europe Drug of Abuse (DOA) Testing Consumables Market Size by Country
        7.3.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2028)
        7.3.2 Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Drug of Abuse (DOA) Testing Consumables Market Size by Type
        8.1.1 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2028)
        8.1.2 Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2028)
    8.2 Asia Pacific Drug of Abuse (DOA) Testing Consumables Market Size by Application
        8.2.1 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2028)
        8.2.2 Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2028)
    8.3 Asia Pacific Drug of Abuse (DOA) Testing Consumables Market Size by Region
        8.3.1 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2028)
        8.3.2 Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Drug of Abuse (DOA) Testing Consumables Market Size by Type
        9.1.1 Latin America Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2028)
        9.1.2 Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2028)
    9.2 Latin America Drug of Abuse (DOA) Testing Consumables Market Size by Application
        9.2.1 Latin America Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2028)
        9.2.2 Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2028)
    9.3 Latin America Drug of Abuse (DOA) Testing Consumables Market Size by Country
        9.3.1 Latin America Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2028)
        9.3.2 Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Market Size by Type
        10.1.1 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2028)
    10.2 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Market Size by Application
        10.2.1 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2028)
    10.3 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Market Size by Country
        10.3.1 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Siemens AG
        11.1.1 Siemens AG Corporation Information
        11.1.2 Siemens AG Overview
        11.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Siemens AG Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Siemens AG Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Corporation Information
        11.4.2 Thermo Fisher Scientific Overview
        11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Thermo Fisher Scientific Recent Developments
    11.5 Bio-Rad
        11.5.1 Bio-Rad Corporation Information
        11.5.2 Bio-Rad Overview
        11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Bio-Rad Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Bio-Rad Recent Developments
    11.6 Abbott
        11.6.1 Abbott Corporation Information
        11.6.2 Abbott Overview
        11.6.3 Abbott Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Abbott Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Abbott Recent Developments
    11.7 Quest Diagnostics
        11.7.1 Quest Diagnostics Corporation Information
        11.7.2 Quest Diagnostics Overview
        11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Quest Diagnostics Recent Developments
    11.8 Psychemedics
        11.8.1 Psychemedics Corporation Information
        11.8.2 Psychemedics Overview
        11.8.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Psychemedics Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Psychemedics Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Drug of Abuse (DOA) Testing Consumables Industry Chain Analysis
    12.2 Drug of Abuse (DOA) Testing Consumables Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Drug of Abuse (DOA) Testing Consumables Production Mode & Process
    12.4 Drug of Abuse (DOA) Testing Consumables Sales and Marketing
        12.4.1 Drug of Abuse (DOA) Testing Consumables Sales Channels
        12.4.2 Drug of Abuse (DOA) Testing Consumables Distributors
    12.5 Drug of Abuse (DOA) Testing Consumables Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Drug of Abuse (DOA) Testing Consumables Industry Trends
    13.2 Drug of Abuse (DOA) Testing Consumables Market Drivers
    13.3 Drug of Abuse (DOA) Testing Consumables Market Challenges
    13.4 Drug of Abuse (DOA) Testing Consumables Market Restraints
14 Key Findings in The Global Drug of Abuse (DOA) Testing Consumables Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Drug of Abuse (DOA) Testing Consumables Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Rapid Test Kits
    Table 3. Major Manufacturers of Assay Kits and Reagents
    Table 4. Major Manufacturers of Others
    Table 5. Global Drug of Abuse (DOA) Testing Consumables Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Drug of Abuse (DOA) Testing Consumables Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2022) & (K Units)
    Table 8. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2017-2022)
    Table 9. Global Drug of Abuse (DOA) Testing Consumables Sales by Region (2023-2028) & (K Units)
    Table 10. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2023-2028)
    Table 11. Global Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region (2017-2022)
    Table 13. Global Drug of Abuse (DOA) Testing Consumables Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region (2023-2028)
    Table 15. Global Drug of Abuse (DOA) Testing Consumables Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Drug of Abuse (DOA) Testing Consumables Sales Share by Manufacturers (2017-2022)
    Table 17. Global Drug of Abuse (DOA) Testing Consumables Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Manufacturers (2017-2022)
    Table 19. Drug of Abuse (DOA) Testing Consumables Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Drug of Abuse (DOA) Testing Consumables Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Drug of Abuse (DOA) Testing Consumables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing Consumables as of 2021)
    Table 22. Drug of Abuse (DOA) Testing Consumables Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Drug of Abuse (DOA) Testing Consumables Product Offered
    Table 24. Date of Manufacturers Enter into Drug of Abuse (DOA) Testing Consumables Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
    Table 27. Global Drug of Abuse (DOA) Testing Consumables Sales by Type (2023-2028) & (K Units)
    Table 28. Global Drug of Abuse (DOA) Testing Consumables Sales Share by Type (2017-2022)
    Table 29. Global Drug of Abuse (DOA) Testing Consumables Sales Share by Type (2023-2028)
    Table 30. Global Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Drug of Abuse (DOA) Testing Consumables Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Type (2017-2022)
    Table 33. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Type (2023-2028)
    Table 34. Drug of Abuse (DOA) Testing Consumables Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Drug of Abuse (DOA) Testing Consumables Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
    Table 37. Global Drug of Abuse (DOA) Testing Consumables Sales by Application (2023-2028) & (K Units)
    Table 38. Global Drug of Abuse (DOA) Testing Consumables Sales Share by Application (2017-2022)
    Table 39. Global Drug of Abuse (DOA) Testing Consumables Sales Share by Application (2023-2028)
    Table 40. Global Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Drug of Abuse (DOA) Testing Consumables Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Application (2017-2022)
    Table 43. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Application (2023-2028)
    Table 44. Drug of Abuse (DOA) Testing Consumables Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Drug of Abuse (DOA) Testing Consumables Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
    Table 47. North America Drug of Abuse (DOA) Testing Consumables Sales by Type (2023-2028) & (K Units)
    Table 48. North America Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Drug of Abuse (DOA) Testing Consumables Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
    Table 51. North America Drug of Abuse (DOA) Testing Consumables Sales by Application (2023-2028) & (K Units)
    Table 52. North America Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Drug of Abuse (DOA) Testing Consumables Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
    Table 55. North America Drug of Abuse (DOA) Testing Consumables Sales by Country (2023-2028) & (K Units)
    Table 56. North America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Drug of Abuse (DOA) Testing Consumables Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Drug of Abuse (DOA) Testing Consumables Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Drug of Abuse (DOA) Testing Consumables Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Drug of Abuse (DOA) Testing Consumables Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Drug of Abuse (DOA) Testing Consumables Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Siemens AG Corporation Information
    Table 107. Siemens AG Description and Major Businesses
    Table 108. Siemens AG Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Siemens AG Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Siemens AG Recent Developments
    Table 111. Merck Corporation Information
    Table 112. Merck Description and Major Businesses
    Table 113. Merck Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Merck Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Merck Recent Developments
    Table 116. Roche Corporation Information
    Table 117. Roche Description and Major Businesses
    Table 118. Roche Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Roche Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Roche Recent Developments
    Table 121. Thermo Fisher Scientific Corporation Information
    Table 122. Thermo Fisher Scientific Description and Major Businesses
    Table 123. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Thermo Fisher Scientific Recent Developments
    Table 126. Bio-Rad Corporation Information
    Table 127. Bio-Rad Description and Major Businesses
    Table 128. Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Bio-Rad Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Bio-Rad Recent Developments
    Table 131. Abbott Corporation Information
    Table 132. Abbott Description and Major Businesses
    Table 133. Abbott Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Abbott Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Abbott Recent Developments
    Table 136. Quest Diagnostics Corporation Information
    Table 137. Quest Diagnostics Description and Major Businesses
    Table 138. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Quest Diagnostics Recent Developments
    Table 141. Psychemedics Corporation Information
    Table 142. Psychemedics Description and Major Businesses
    Table 143. Psychemedics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Psychemedics Drug of Abuse (DOA) Testing Consumables Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Psychemedics Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Drug of Abuse (DOA) Testing Consumables Distributors List
    Table 149. Drug of Abuse (DOA) Testing Consumables Customers List
    Table 150. Drug of Abuse (DOA) Testing Consumables Market Trends
    Table 151. Drug of Abuse (DOA) Testing Consumables Market Drivers
    Table 152. Drug of Abuse (DOA) Testing Consumables Market Challenges
    Table 153. Drug of Abuse (DOA) Testing Consumables Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug of Abuse (DOA) Testing Consumables Product Picture
    Figure 3. Global Drug of Abuse (DOA) Testing Consumables Market Share by Type in 2021 & 2028
    Figure 3. Rapid Test Kits Product Picture
    Figure 4. Assay Kits and Reagents Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Drug of Abuse (DOA) Testing Consumables Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Laboratories
    Figure 9. Workplace
    Figure 10. At-Home
    Figure 11. Others
    Figure 12. Drug of Abuse (DOA) Testing Consumables Report Years Considered
    Figure 13. Global Drug of Abuse (DOA) Testing Consumables Sales 2017-2028 (K Units)
    Figure 14. Global Drug of Abuse (DOA) Testing Consumables Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Drug of Abuse (DOA) Testing Consumables Revenue 2017-2028 (US$ Million)
    Figure 16. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2017-2022)
    Figure 18. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2023-2028)
    Figure 19. North America Drug of Abuse (DOA) Testing Consumables Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Drug of Abuse (DOA) Testing Consumables Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Drug of Abuse (DOA) Testing Consumables Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Drug of Abuse (DOA) Testing Consumables Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Drug of Abuse (DOA) Testing Consumables Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Drug of Abuse (DOA) Testing Consumables Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Drug of Abuse (DOA) Testing Consumables Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Drug of Abuse (DOA) Testing Consumables Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Drug of Abuse (DOA) Testing Consumables Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Drug of Abuse (DOA) Testing Consumables in the World: Market Share by Drug of Abuse (DOA) Testing Consumables Revenue in 2021
    Figure 31. Global Drug of Abuse (DOA) Testing Consumables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2028)
    Figure 33. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2028)
    Figure 34. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2028)
    Figure 35. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2028)
    Figure 36. North America Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2028)
    Figure 37. North America Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2028)
    Figure 38. North America Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2028)
    Figure 39. North America Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2028)
    Figure 40. North America Drug of Abuse (DOA) Testing Consumables Sales Share by Country (2017-2028)
    Figure 41. North America Drug of Abuse (DOA) Testing Consumables Revenue Share by Country (2017-2028)
    Figure 42. U.S. Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2028)
    Figure 45. Europe Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2028)
    Figure 47. Europe Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Drug of Abuse (DOA) Testing Consumables Sales Share by Country (2017-2028)
    Figure 49. Europe Drug of Abuse (DOA) Testing Consumables Revenue Share by Country (2017-2028)
    Figure 50. Germany Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 51. France Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue Share by Region (2017-2028)
    Figure 61. China Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 64. India Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Drug of Abuse (DOA) Testing Consumables Sales Share by Country (2017-2028)
    Figure 76. Latin America Drug of Abuse (DOA) Testing Consumables Revenue Share by Country (2017-2028)
    Figure 77. Mexico Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue Share by Country (2017-2028)
    Figure 86. Turkey Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Drug of Abuse (DOA) Testing Consumables Revenue (2017-2028) & (US$ Million)
    Figure 89. Drug of Abuse (DOA) Testing Consumables Value Chain
    Figure 90. Drug of Abuse (DOA) Testing Consumables Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Siemens AG
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Frequently Asked Questions
Drug of Abuse (DOA) Testing Consumables report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drug of Abuse (DOA) Testing Consumables report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drug of Abuse (DOA) Testing Consumables report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Solar Encapsulant

Solar Encapsulant market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

IVF Instruments

IVF Instruments market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More